Bay area biotech StemCells to wind down.

Bay area biotech StemCells to wind down.

They were working on a spinal chord treatment but their clinical trials have failed. Bay area biotech “StemCells” (I was surprised they didn’t “invest” in the .com version of their name) which was publicly traded  will wind down operations. They are hoping to see what can be salvaged for investors and skirt a 100% loss. At their peak: $74 million market cap. Now, not so much. ($6 million) They also raised 32 million in two…

Read More
1 2